Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic Risk Factors in Drug‐Induced Liver Injury Due to Isoniazid‐Containing Antituberculosis Drug Regimens
Paola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Clinical Pharmacology & Therapeutics (2020) Vol. 109, Iss. 4, pp. 1125-1135
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice
Marina Villanueva-Paz, L. Ortega Morán, Nuria López‐Alcántara, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 390-390
Open Access | Times Cited: 121
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Robert J. Fontana, Iris Liou, Adrian Reuben, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 1036-1065
Open Access | Times Cited: 115
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Harshad Devarbhavi, Guruprasad P. Aithal, Sombat Treeprasertsuk, et al.
Hepatology International (2021) Vol. 15, Iss. 2, pp. 258-282
Closed Access | Times Cited: 114
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
Joseph Clinton, Sara Kiparizoska, Soorya Aggarwal, et al.
Drug Safety (2021) Vol. 44, Iss. 11, pp. 1125-1149
Open Access | Times Cited: 67
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Yimin Mao, Shiwu Ma, Chenghai Liu, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 384-419
Closed Access | Times Cited: 12
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative
Eric Cohen, Meenal Patwardhan, Ritu Raheja, et al.
Drug Safety (2024) Vol. 47, Iss. 4, pp. 301-319
Open Access | Times Cited: 7
The integration of omics: A promising approach to personalized tuberculosis treatment
Priyanka Guha, Siddhartha Dutta, Krishna Murti, et al.
Medicine in Omics (2024) Vol. 12, pp. 100033-100033
Open Access | Times Cited: 7
Influence of N -acetyltransferase 2 polymorphisms and clinical variables on liver function profile of tuberculosis patients
Levin Thomas, Arun Prasath Raju, S. Chaithra, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 3, pp. 263-274
Open Access | Times Cited: 7
Genetics of drug‐induced liver injury: Current knowledge and future prospects
Ann K. Daly
Clinical and Translational Science (2022) Vol. 16, Iss. 1, pp. 37-42
Open Access | Times Cited: 27
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles
Chiratidzo R. Chamboko, Wayde Veldman, Rolland Bantar Tata, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3383-3383
Open Access | Times Cited: 15
Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
Thanakorn Surarak, Supatat Chumnumwat, Wichit Nosoongnoen, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 6
Epidemiology of liver failure in Asia‐Pacific region
Ankur Jindal, Shiv Kumar Sarin
Liver International (2022) Vol. 42, Iss. 9, pp. 2093-2109
Open Access | Times Cited: 20
Drug induced cholestatic liver diseases
Einar S. Björnsson, Harshad Devarbhavi
Hepatology (2024)
Closed Access | Times Cited: 4
Egr1 confers protection against acetaminophen‑induced hepatotoxicity via transcriptional upregulating of Acaa2
Xiaohong Lei, Qingling Xu, Chunmin Li, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 9, pp. 3800-3817
Open Access | Times Cited: 19
Anti-tuberculosis drug-induced liver injury
Wei Shen Lim, Anthony Avery, Onn Min Kon, et al.
BMJ (2023), pp. e074866-e074866
Closed Access | Times Cited: 11
Association of NAT2 promoter hypermethylation with susceptibility to hepatotoxicity due to antituberculosis drugs and biomarker potential
Jiraphun Jittikoon, Wacharapol Saengsiwaritt, Noppadol Chanhom, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epigenetic modifications in drug‐induced liver injury: A systematic review
Romina Lorena de los Santos‐Fernández, Antonio Segovia‐Zafra, Guillermo Paz‐López, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Genetic Control of the Transcriptional Response to Active Tuberculosis Disease and Treatment
John P. Grady, Alexander S. Leonard, Houcheng Li, et al.
(2025)
Closed Access
Incidence and associated risk factors of antituberculosis drug induced hepatotoxicity among TB patients
Vincent Aketch Nyangwara, Ziyaad Waja, Roslyn Thelingwani, et al.
Research Square (Research Square) (2025)
Closed Access
Clinical and Genetic Risk Factors for Drug-Induced Liver Injury Associated with Anti-Tuberculosis Treatment—A Study from Patients of Portuguese Health Centers
M.J. Cavaco, Celeste Alcobia, Bárbara Oliveiros, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 790-790
Open Access | Times Cited: 16
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
Jihoon G. Yoon, Dong Geon Jang, Sung-Gyu Cho, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 570-582
Open Access | Times Cited: 3
Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis
Ramesh Kumar, Abhishek Kumar, Rishabh Patel, et al.
Indian Journal of Gastroenterology (2024) Vol. 44, Iss. 1, pp. 35-46
Closed Access | Times Cited: 3
A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions
Abdelbaset Elzagallaai, Awatif M. Abuzgaia, Michael Rieder
Expert Opinion on Drug Metabolism & Toxicology (2025)
Closed Access
Idiosyncratic Drug-Induced Liver Injury: Mechanisms and Susceptibility Factors
Camilla Stephens, M. Isabel Lucena, Raúl J. Andrade
Elsevier eBooks (2025)
Closed Access
Functional Characterization of the Effects of N-acetyltransferase 2 Alleles on N-acetylation of Eight Drugs and Worldwide Distribution of Substrate-Specific Diversity
Koya Fukunaga, Ken Kato, Takuji Okusaka, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top